Mikogami T, Marianne T, Spik G
Laboratoire de Chimie Biologique, Université des Sciences et Technologies de Lille, Villeneuve d'Ascq, France.
Biochem J. 1995 Jun 1;308 ( Pt 2)(Pt 2):391-7. doi: 10.1042/bj3080391.
A lactoferrin receptor has been found on the brush-border membrane of intestinal epithelial cells of several species, including humans. A role for this receptor in intestinal iron absorption, which is well regulated in response to body iron stores, has been proposed. We have investigated the effect of intracellular iron depletion by picolinic acid, an iron chelator, on the cell surface binding of human lactoferrin to human enterocytes and its intracellular uptake, using HT29-18-C1 cells, an enterocyte-like differentiable cell line. The confluent cells exhibited 5.8 x 10(6) specific binding sites per cell for diferric human 125I-labelled lactoferrin with relatively low affinity (Kd 8.4 x 10(-7) M). The addition of picolinic acid to the culture medium resulted in a concentration- and time-dependent increase in lactoferrin binding that was correlated with a decrease in intracellular iron content. The maximum effect of picolinic acid on lactoferrin binding (approx. 2-fold increase), which appeared between 12 and 18 h after its addition, was obtained at a picolinic acid concentration of 2 mM. Scatchard analysis showed that the enhanced lactoferrin binding resulted from an increase in the number of lactoferrin receptors rather than an alteration in the binding affinity for lactoferrin. The time-dependent effect of picolinic acid was completely abolished in the presence of 1 microM anisomycin, a protein synthesis inhibitor, indicating that ongoing protein synthesis is involved in this effect. The enhanced lactoferrin binding induced by picolinic acid produced an increase of approx. 30% in the uptake of lactoferrin-bound 59Fe, indicating the existence of functional receptors. These results suggest that biosynthesis of lactoferrin receptors in intestinal epithelial cells can be regulated in response to the levels of intracellular chelatable iron, consistent with intestinal iron absorption dependent on body iron stores.
在包括人类在内的多个物种的肠道上皮细胞刷状缘膜上发现了乳铁蛋白受体。有人提出该受体在肠道铁吸收中发挥作用,而肠道铁吸收会根据体内铁储备进行良好调节。我们使用HT29-18-C1细胞(一种类似肠上皮细胞的可分化细胞系),研究了铁螯合剂吡啶甲酸导致的细胞内铁耗竭对人乳铁蛋白与人肠上皮细胞的细胞表面结合及其细胞内摄取的影响。汇合的细胞对二价铁的人125I标记乳铁蛋白表现出每细胞5.8×10(6)个特异性结合位点,亲和力相对较低(解离常数Kd为8.4×10(-7)M)。向培养基中添加吡啶甲酸导致乳铁蛋白结合呈浓度和时间依赖性增加,这与细胞内铁含量的降低相关。吡啶甲酸对乳铁蛋白结合的最大作用(约增加2倍)在添加后12至18小时出现,在吡啶甲酸浓度为2 mM时获得。Scatchard分析表明,乳铁蛋白结合增强是由于乳铁蛋白受体数量增加,而非对乳铁蛋白的结合亲和力改变。在存在1 microM茴香霉素(一种蛋白质合成抑制剂)的情况下,吡啶甲酸的时间依赖性作用完全消除,表明正在进行的蛋白质合成参与了这一作用。吡啶甲酸诱导的乳铁蛋白结合增强使结合乳铁蛋白的59Fe摄取增加了约30%,表明存在功能性受体。这些结果表明,肠道上皮细胞中乳铁蛋白受体的生物合成可根据细胞内可螯合铁的水平进行调节,这与依赖于体内铁储备的肠道铁吸收一致。